Hani Saeed, DPM
Primary Podiatric Medicine · Denver, CONPI 1154397073
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.
Across 48 payments — averaging $44.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$389
- Smith+Nephew$317
- Angiodynamics, Inc.$268
- Paratek Pharmaceuticals, Inc.$166
- Amgen$163
- Convatec Inc.$141
- plus $691 from 18 others
What the payments were for
- Food & beverage$2,136100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $389 |
| Smith+Nephew | 6 | $317 |
| Angiodynamics, Inc. | 2 | $268 |
| Paratek Pharmaceuticals, Inc. | 5 | $166 |
| Amgen | 3 | $163 |
| Convatec Inc. | 1 | $141 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $132 |
| Boston Scientific | 4 | $97 |
| Paragon 28, Inc. | 5 | $92 |
| Zimmer Biomet | 2 | $63 |
| Stryker | 1 | $49 |
| Mimedx Group, Inc. | 2 | $42 |
| Linvatec Corporation | 1 | $38 |
| Dexcom, Inc. | 1 | $29 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $25 |
| Organogenesis Inc. | 1 | $25 |
| Heron Therapeutics, Inc. | 1 | $14 |
| Curonix LLC | 1 | $14 |
| Lifenet Health | 1 | $14 |
| Integra Lifesciences Corporation | 1 | $14 |
| Arteriocyte Medical Systems, Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $11 |
| Melinta Therapeutics, LLC | 1 | $11 |
| Royal Biologics, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Abre$370
- Santyl$245
- InnovaMatrix AC$141
- Auryon Laser System 100-120 Vac$127
- KRYSTEXXA$124
- REGRANEX$122
- Oasis$122
- NUZYRA$108
How this compares
Too few primary podiatric medicine providers in Coloradoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 93 | $1,559 |
| Cephalexin | 108 | $1,002 |
| Amitriptyline Hcl | 45 | $649 |
| Doxycycline Hyclate | 12 | $126 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $123 |
| Indomethacin | 12 | $103 |
| Methylprednisolone | 12 | $101 |
| Meloxicam | 20 | $38 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Denver
- Kevin DericksonDenver$2K
- Frederick MechanikDenver$1K
- Garrett MooreDenver$410
- Stephen AlbertDenver$76
- Edward RaczkaDenver$67
- Kristen TrelevenGreeley$7K
- Jennifer YullColorado Springs$1K
- Michael ThomasFort Collins$669
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.